Literature DB >> 15812619

A framework for examining the sustained acceptability of microbicides.

Lawrence J Severy1, Elizabeth Tolley, Cynthia Woodsong, Greg Guest.   

Abstract

The concept of acceptability involves a complex set of individual, couple and socio-cultural factors. Within a specific focus on microbicides, this article sets forth the relevant behavioral issues demanding attention as scientists and product developers strive to identify microbicides that will be used in a sustained, long-term fashion to prevent HIV/AIDS. The paper re-conceptualizes long-term acceptability within the ARRM framework, reviews the basic issues and research related to microbicide acceptability, discusses couple relationships (especially the nature of intimate relationships), and identifies related gender and power factors. The importance of the cultural context within various international settings pervades all of these issues. Finally, a set of challenges is discussed for those contemplating such research.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15812619     DOI: 10.1007/s10461-005-1687-y

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  37 in total

1.  Sexual communication among married couples in the context of a microbicide clinical trial and acceptability study in Pune, India.

Authors:  Heather M Marlow; Elizabeth E Tolley; Rewa Kohli; Sanjay Mehendale
Journal:  Cult Health Sex       Date:  2010-11

2.  Assessing microbicide acceptability: a comprehensive and integrated approach.

Authors:  Kathleen M Morrow; Monica S Ruiz
Journal:  AIDS Behav       Date:  2007-06-26

3.  Microbicide acceptability among female sex workers in Beijing, China: results from a pilot study.

Authors:  Lin Han; Fan Lv; Peng Xu; Guolei Zhang; Naomi S Juniper; Zhenglai Wu
Journal:  J Womens Health (Larchmt)       Date:  2009-09       Impact factor: 2.681

4.  Attitudes towards microbicide use for bacterial vaginosis in pregnancy.

Authors:  Marina Catallozzi; Camille Y Williams; Gregory D Zimet; Katharine M Hargreaves; Shari E Gelber; Adam J Ratner; Lawrence R Stanberry; Susan L Rosenthal
Journal:  Sex Health       Date:  2014-09       Impact factor: 2.706

Review 5.  Acceptability in microbicide and PrEP trials: current status and a reconceptualization.

Authors:  Barbara S Mensch; Ariane van der Straten; Lauren L Katzen
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

6.  Adherence and acceptability in MTN 001: a randomized cross-over trial of daily oral and topical tenofovir for HIV prevention in women.

Authors:  Alexandra M Minnis; Sharavi Gandham; Barbra A Richardson; Vijayanand Guddera; Beatrice A Chen; Robert Salata; Clemensia Nakabiito; Craig Hoesley; Jessica Justman; Lydia Soto-Torres; Karen Patterson; Kailazarid Gomez; Craig W Hendrix
Journal:  AIDS Behav       Date:  2013-02

7.  Adherence to diaphragm use for infection prevention: a prospective study of female sex workers in Kenya.

Authors:  Elizabeth A Bukusi; Maria F Gallo; Anjali Sharma; Betty Njoroge; Denise J Jamieson; Rosemary Nguti; April J Bell; David A Eschenbach
Journal:  Infect Dis Obstet Gynecol       Date:  2010-03-07

8.  PVP-coated silver nanoparticles block the transmission of cell-free and cell-associated HIV-1 in human cervical culture.

Authors:  Humberto H Lara; Liliana Ixtepan-Turrent; Elsa N Garza-Treviño; Cristina Rodriguez-Padilla
Journal:  J Nanobiotechnology       Date:  2010-07-13       Impact factor: 10.435

9.  Health practices and vaginal microbicide acceptability among urban black women.

Authors:  Marian Reiff; Christine Wade; Maria T Chao; Fredi Kronenberg; Linda F Cushman
Journal:  J Womens Health (Larchmt)       Date:  2008-10       Impact factor: 2.681

10.  Assessment of a Microbicide Candidate among a Diverse Cohort of Urban Southern US Women and their Male Sexual Partners.

Authors:  Paula Frew; Kimberly Parker; Takeia Horton; Brooke Hixson; Lisa Flowers; Frances Priddy; Lisa Grohskopf; Christine Mauck; Kimberly Workowski
Journal:  J AIDS Clin Res       Date:  2012-07-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.